Profile data is unavailable for this security.
About the company
Dignitana AB is a Sweden-based medical technology company. It develops, manufactures and markets a medical device primarily used for scalp cooling in order to eliminate or reduce chemotherapy induced hair loss. The Company focuses on the product DigniCap, which counteracts hair loss during chemotherapy. The product is a cold cap, which when put on the patient’s head, lowers the temperature of the scalp. The low temperature reduces perfusion, delivery of blood and metabolism. The reduced blood flow results in a smaller amount of chemotherapy available for uptake in the cells, while the decreased temperature results in less absorption and reduced effects of chemotherapy. These factors together reduce the risk of hair loss. The DigniCap scalp cooling system is patented in Europe, Japan and the United States. It has a subsidiary BrainCool AB, which focuses on producing different models of brain cooling for stroke and cardiac arrest patients.
- Revenue in SEK (TTM)86.06m
- Net income in SEK-17.36m
- Incorporated2007
- Employees27.00
- LocationDignitana ABTraktorgranden 3LUND 226 60SwedenSWE
- Phone+46 46163090
- Fax+46 46163099
- Websitehttps://dignitana.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ProstaLund AB | 22.21m | -17.01m | 82.72m | -- | -- | 1.50 | -- | 3.72 | -0.2469 | -0.2469 | 0.3237 | 0.7219 | 0.3811 | 0.5004 | 8.84 | -- | -29.19 | -29.15 | -34.28 | -35.01 | 70.49 | 75.26 | -76.61 | -68.94 | 2.16 | -105.99 | 0.0235 | -- | 27.54 | 10.36 | -53.27 | -- | 20.35 | -- |
| Luxbright AB | -466.64k | -23.07m | 90.93m | -- | -- | 1.93 | -- | -- | -0.3717 | -0.3717 | -0.0068 | 0.5101 | -0.0103 | -- | -- | -- | -50.99 | -52.69 | -53.38 | -60.37 | -- | -- | -- | -2,130.96 | -- | -- | 0.0044 | -- | 67.10 | -- | 38.77 | -- | -- | -- |
| Nanexa AB | 29.33m | -76.40m | 93.36m | 19.00 | -- | 0.9742 | -- | 3.18 | -0.9353 | -0.9353 | 0.4181 | 0.7062 | 0.1939 | -24.88 | 4.10 | 1,543,526.00 | -50.52 | -40.77 | -65.56 | -48.77 | 201.72 | 346.62 | -260.50 | -532.26 | 2.47 | -- | 0.0404 | -- | 925.42 | 147.00 | -30.44 | -- | 39.10 | -- |
| Iconovo AB | 8.47m | -42.40m | 94.05m | 29.00 | -- | 0.947 | -- | 11.10 | -3.68 | -3.68 | 0.703 | 8.45 | 0.0554 | -- | 1.24 | 292,079.00 | -27.74 | -25.43 | -30.85 | -28.24 | 234.21 | 134.57 | -500.63 | -215.16 | -- | -- | 0.0666 | -- | -58.65 | -9.88 | 4.71 | -- | 34.70 | -- |
| ScandiDos AB | 65.08m | -4.85m | 98.06m | 34.00 | -- | 2.27 | -- | 1.51 | -0.1063 | -0.1063 | 1.43 | 0.7588 | 0.9573 | 0.4787 | 7.39 | -- | -7.14 | -13.82 | -13.39 | -23.95 | 82.54 | 82.49 | -7.45 | -17.09 | 0.4511 | -2.63 | 0.00 | -- | 6.70 | 4.01 | -24.27 | -- | 4.18 | -- |
| Episurf Medical AB | 11.10m | -92.10m | 101.31m | 25.00 | -- | 1.58 | -- | 9.13 | -0.3449 | -0.3449 | 0.0416 | 0.2411 | 0.086 | -- | 5.29 | 396,428.60 | -71.42 | -47.46 | -81.48 | -52.01 | -- | -- | -830.63 | -1,019.29 | 2.54 | -- | 0.068 | -- | 53.62 | 19.78 | -22.64 | -- | -0.4158 | -- |
| Observe Medical ASA | -99.45bn | -99.45bn | 105.06m | -- | -- | 0.4022 | -- | -- | -- | -- | -- | 1.38 | -- | -- | -- | -- | -- | -31.10 | -- | -51.60 | -- | 33.76 | -- | -274.82 | 0.0711 | -- | 0.3526 | -- | -18.80 | 150.54 | -93.01 | -- | 25.73 | -- |
| BBS-Bioactive Bone Substitutes Oyj | 0.00 | -40.57m | 110.14m | -- | -- | 1.76 | -- | -- | -0.2926 | -0.2926 | 0.00 | 0.2647 | 0.00 | -- | -- | -- | -32.71 | -25.12 | -38.23 | -28.54 | -- | -- | -- | -- | -- | -28.79 | 0.482 | -- | -- | -- | -12.64 | -- | -- | -- |
| Redsense Medical AB (publ) | 24.97m | -4.51m | 111.20m | 5.00 | -- | 4.82 | -- | 4.45 | -0.3214 | -0.3214 | 1.78 | 1.64 | 0.8724 | 8.18 | 6.32 | 4,993,400.00 | -15.77 | -18.66 | -17.96 | -20.99 | 52.70 | 69.02 | -18.08 | -46.28 | 3.49 | -- | 0.00 | -- | 74.11 | 28.94 | 48.47 | -- | -23.62 | -- |
| Ortivus AB | 84.08m | -18.25m | 118.50m | 40.00 | -- | 6.63 | -- | 1.41 | -0.4118 | -0.4118 | 1.90 | 0.3906 | 0.9709 | -- | 10.67 | 2,102,025.00 | -21.07 | -2.41 | -32.63 | -4.63 | 36.68 | 42.46 | -21.70 | -1.77 | 0.6327 | -- | 0.2405 | -- | -19.55 | 10.00 | -409.66 | -- | 67.43 | -- |
| BibbInstruments AB | 0.00 | -10.97m | 122.04m | -- | -- | 3.91 | -- | -- | -0.4379 | -0.4379 | 0.00 | 1.18 | 0.00 | -- | -- | -- | -32.19 | -39.57 | -34.83 | -42.71 | -- | 59.36 | -- | -8,032.40 | 4.67 | -- | -- | -- | -- | -- | 2.72 | -- | -1.94 | -- |
| Clinical Laserthermia Systems AB | 8.27m | -79.79m | 127.54m | 7.00 | -- | 2.58 | -- | 15.42 | -23.38 | -23.38 | 2.00 | 6.29 | 0.1543 | 10.95 | 4.20 | -- | -150.84 | -123.49 | -292.98 | -312.95 | -508.29 | -1,084.16 | -977.58 | -1,625.03 | 1.50 | -5.24 | 0.0103 | -- | 31.99 | 35.55 | -12.92 | -- | 18.61 | -- |
| Dignitana AB | 86.06m | -17.36m | 128.87m | 27.00 | -- | 15.52 | -- | 1.50 | -0.2464 | -0.2464 | 1.22 | 0.1031 | 1.66 | 4.35 | 15.07 | 3,187,519.00 | -33.59 | -42.21 | -74.20 | -68.91 | 68.52 | 66.09 | -20.17 | -57.29 | 0.4633 | -6.82 | 0.7245 | -- | 17.90 | 20.59 | 22.52 | -- | -15.31 | -- |
| Neola Medical AB | 0.00 | -9.01m | 132.58m | 7.00 | -- | 1.68 | -- | -- | -0.1616 | -0.1616 | 0.00 | 1.13 | 0.00 | -- | -- | 0.00 | -11.17 | -17.04 | -12.03 | -18.46 | -- | 4,237.20 | -- | -5,258.78 | -- | -- | 0.00 | -- | -- | -- | 12.97 | -- | 55.46 | -- |
| Acousort AB | 5.54m | -17.09m | 156.81m | -- | -- | 6.48 | -- | 28.33 | -1.23 | -1.23 | 0.4049 | 1.62 | 0.1457 | 5.10 | 2.52 | -- | -44.97 | -48.62 | -79.33 | -69.77 | -69.83 | -68.05 | -308.76 | -299.58 | 2.76 | -- | 0.00 | -- | 11.51 | 38.81 | -24.01 | -- | -- | -- |
| Arcoma AB | 171.89m | 9.40m | 172.73m | 31.00 | 18.37 | 3.27 | 10.47 | 1.00 | 0.713 | 0.713 | 13.04 | 4.01 | 1.81 | 3.71 | 6.93 | 5,544,871.00 | 9.92 | 1.12 | 18.49 | 2.01 | 36.83 | 37.66 | 5.47 | 0.7568 | 0.9788 | 11.95 | 0.0475 | 0.00 | 30.36 | 6.41 | 34.81 | -- | 22.75 | -- |
Data as of May 03 2024. Currency figures normalised to Dignitana AB's reporting currency: Swedish Krona SEK
16.88%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Swedbank Robur Fonder ABas of 29 Feb 2024 | 5.42m | 7.68% |
| Handelsbanken Fonder ABas of 31 Mar 2024 | 4.68m | 6.64% |
| FCG Fonder ABas of 30 Jun 2022 | 1.80m | 2.55% |
Data from 31 Oct 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
